Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel von Hadji, P., Coleman, R.E., Wilson, C., Powles, T.J., Clézardin, P., Aapro, M., Costa, L., Body, J.-J., Markopoulos, C., Santini, D., Diel, I., Di Leo, A., Cameron, D., Dodwell, D., Smith, I., Gnant, M., Gray, R., Harbeck, N., Thurlimann, B., Untch, M., Cortes, J., Martin, M., Albert, U.-S., Conte, P.-F., Ejlertsen, B., Bergh, J., Kaufmann, M., Holen, I.

Volltext

Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs von Stresing, V, Baltziskueta, E, Rubio, N, Blanco, J, Arriba, MaC, Valls, J, Janier, M, Clézardin, P, Sanz-Pamplona, R, Nieva, C, Marro, M, Dmitri, P, Sierra, A

Volltext

The RANK–RANKL axis: an opportunity for drug repurposing in cancer? von Peters, S., Clézardin, P., Márquez-Rodas, I., Niepel, D., Gedye, C.

Volltext

Increased Dickkopf-1 expression in breast cancer bone metastases von Voorzanger-Rousselot, N, Goehrig, D, Journe, F, Doriath, V, Body, J J, Clézardin, P, Garnero, P

Volltext

Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo von Gibert, B, Eckel, B, Gonin, V, Goldschneider, D, Fombonne, J, Deux, B, Mehlen, P, Arrigo, A-P, Clézardin, P, Diaz-Latoud, C

Volltext

RANK expression predicts long term outcome in early luminal breast cancer von Kassem, L., Clézardin, P., Treilleux, I.

Volltext

ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors von Vargas, G., Bouchet, M., Bouazza, L., Reboul, P., Boyault, C., Gervais, M., Kan, C., Benetollo, C., Brevet, M., Croset, M., Mazel, M., Cayrefourcq, L., Geraci, S., Vacher, S., Pantano, F., Filipits, M., Driouch, K., Bieche, I., Gnant, M., Jacot, W., Aubin, J. E., Duterque-Coquillaud, M., Alix-Panabières, C., Clézardin, P., Bonnelye, E.

Volltext

Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma von Massy, E, Rousseau, JC, Gueye, M., Bonnelye, E., Brevet, M., Chambard, L., Duruisseaux, M., Borel, O., Roger, C., Guelminger, R., Pialat, J.B., Gineyts, E., Bouazza, L., Millet, M., Maury, JM, Clézardin, P., Girard, N., Confavreux, Cyrille B.

Volltext

Early Detection of Bone Metastases in a Murine Model Using Fluorescent Human Breast Cancer Cells: Application to the Use of the Bisphosphonate Zoledronic Acid in the Treatment of O... von Peyruchaud, Olivier, Winding, Bent, Pécheur, Isabelle, Serre, Claire‐Marie, Delmas, Pierre, Clézardin, Philippe

Volltext

The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis von Gineyts, Evelyne, Bonnet, Nicolas, Bertholon, Cindy, Millet, Marjorie, Pagnon-Minot, Aurélie, Borel, Olivier, Geraci, Sandra, Bonnelye, Edith, Croset, Martine, Suhail, Ali, Truica, Cristina, Lamparella, Nicholas, Leitzel, Kim, Hartmann, Daniel, Chapurlat, Roland, Lipton, Allan, Garnero, Patrick, Ferrari, Serge, Clézardin, Philippe, Rousseau, Jean-Charles

Volltext

Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vγ9Vδ2 T cell cytotoxicity in PC-3 prostate cancer cells von Arkko, S, Zlatev, H.P, Mönkkönen, H, Räikkönen, J, Benzaïd, I, Clézardin, P, Mönkkönen, J, Määttä, J.A

Volltext

The role of the calcium sensing receptor in the migration of breast cancer cells von Thiem, U, Boudot, C, Lopez, I, Hénaut, L, Clézardin, P, Kamel, S, Mentaverri, R

Volltext

Effects of Bone-Targeted Agents on Cancer Progression and Mortality von COLEMAN, Robert, GNANT, Michael, MORGAN, Gareth, CLEZARDIN, Philippe

Volltext

97PRANK expression predicts long term outcome in early luminal breast cancer von Kassem, L, Clézardin, P, Treilleux, I

Volltext

Erratum to “Periostin as a circulating marker for breast cancer bone metastases” [Bone 47S2 (2010) S328–S329] von Contié, S, Voorzanger-Rousselot, N, Litvin, J, Clézardin, P, Garnero, P

Volltext

Zoledronic acid induces IPP accumulation and release from human cancer cells, which activates Vγ9Vδ2 T cell-differentiation and migration in vitro and mediates Vγ9Vδ2 T cell-induce... von Benzaid, I, Monkkonen, H, Stresing, V, Bonnelye, E, Green, J, Monkkonen, J, Clézardin, P

Volltext

Twist 1 expression in an osteotropic breast cancer cell line promotes bone metastasis formation in mouse von Croset, M, Goëhrig, D, Bonnelye, E, Ansieau, S, Puisieux, A, Clézardin, P

Volltext

Interaction of autotaxin with breast cancer cell integrins might contribute to lysophosphatidic acid-mediated bone metastases von David, M, Leblanc, R, Deux, B, Serre, C.M, Ribeiro, J, Clézardin, P, Peyruchaud, O

Volltext

Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells von BELLAHCENE, A, BACHELIER, R, DETRY, C, LIDEREAU, R, CLEZARDIN, P, CASTRONOVO, V

Volltext

Effect of lysophosphatidic acid (LPA) on osteoclastogenesis von Serre, C.M, Ribeiro, J, Bonnelye, E, Clézardin, P, Peyruchaud, O

Volltext